SelectEvidenceTM: Complete Cybersecurity Medical Device Risk Assessment Platform

Transform the way you carry out risk assessments for your connected medical devices. SelectEvidenceTM from Nova Leah provides manufacturers with an intelligent, automated, and traceable approach to medical device cybersecurity risk management by continually monitoring SBOMs across their connected medical devices.

REQUEST A DEMO

Centralized Cybersecurity Risk Management

SelectEvidenceTM is an expert cybersecurity risk assessment platform that guides medical device manufacturers through the process of identifying applicable vulnerabilities and identifying the right security controls to mitigate those risks. It provides device manufacturers with an intelligent, automated, and traceable approach to cybersecurity assessments. SelectEvidenceTM does this by continually monitoring SBOMs across all connected medical devices.

Accelerated Analysis

Proprietary algorithms inform
accelerated analysis, greatly
cutting the time needed to
manage risk.

Decision Support

For every vulnerability identified,
specific and actionable
suggested mitigations are
provided.

medical device continual monitoring

Continuous Monitoring
& Alerts

Scanning over 180K
vulnerabilities in real-time,
harnessing automation for
24/7 peace of mind.

medical device enterprise level reporting

Enterprise Level Reporting

Multi-level access and
reporting available for
compliance transparency
and visibility.

Standards-Based

Linked to industry standards,
leverage key repositories
for controls threats and
vulnerabilities.

medical device auto ingest sboms

Auto-Ingest SBOMs

Simple and automated ingestion
of each SBOM makes it easy
and fast to start monitoring
and managing risk.

Accelerate

Premarket cybersecurity risk analysis

Save Time

Postmarket continuously monitoring vulnerabilities

Leveraging SelectEvidenceTM as an integral part of your product development lifecycle for security risk assessment ensures your connected medical devices meet EU and FDA Premarket Submission and Postmarket Management guidelines.

List vulnerabilities, evaluate threats

When we evaluate the risks related to a particular medical device, SelectEvidenceTM lists vulnerabilities and sorts them into high, medium, and low categories, making it easy to prioritize the work needed.

Once a vulnerability has been managed, the risk score displayed on the dashboard is reduced. Each product has a graph that tracks acceptable and current risk levels, which will adjust in real-time as each vulnerability is identified and handled.

As you mitigate threats and vulnerabilities, your overall risk score improves. The platform evaluates risks and also guides you through the process of mitigating those risks by way of security controls.

SelectEvidenceTM not only identifies known vulnerabilities, it also enables you to manually upload outputs from in-house testing tools, including pen tests and static analysis tests.

Claim Your Free Trial

Nova Leah has developed a simple, clear-cut, free trial process.
Discover how SelectEvidenceTM can transform your risk management processes with an intelligent, standardized, repeatable, and traceable approach to implementing cybersecurity requirements across all your connected medical devices.
  1. Step one: Learn how to use the platform with a detailed product demo

  2. Step two: Start your free five-day evaluation mapped to your specific success criteria

  3. Step three: Integrate SelectEvidenceTM into your product development lifecycle and enjoy the benefits!

  1. Step one: Learn how to use the platform with a detailed product demo

  2. Step two: Start your free five-day evaluation mapped to your specific success criteria

  3. Step three: Integrate SelectEvidenceTM into your product development lifecycle and enjoy the benefits!

Claim your free trial

We’d Love to Talk!

Our friendly team of experts are here to help. If you’d like to find out more about SelectEvidenceTM let’s talk!
LET'S TALK
As Seen In

“Maintaining strong cybersecurity is critical throughout the lifecycle of medical devices to keep patients safe and better protect the public health.’ 

FDA.GOV – responsible for ensuring the safety and security of medical devices

Nova Leah

Nova Leah is a world leader in the provision of cybersecurity solutions for medical device manufacturers and healthcare providers. With operations in the US and in Ireland, Nova Leah’s software helps connected medical device manufacturers meet cybersecurity compliance requirements throughout the entire product lifecycle. 

FIND OUT MORE

Industry News

About Nova Leah

Nova Leah is a world leader in centralized risk management systems. Our solutions, designed by industry experts, provide complete oversight of medical device vulnerabilities and threats, and automate the management and mitigation of risk.

Join our team: We Are Hiring!

Site Links

Home
Solutions
About
Contact

Newsletter

Ireland
P: +353 42 93 43 0 33
Block 3, Finnabair Business &
Technology Park, Dundalk, Co Louth, Ireland A91 XR61

US
P: +1 617 314 7010
6th Floor, 399 Boylston Street,
Boston, MA 02116,
United States

Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Youtube
Consent to display content from Youtube
Vimeo
Consent to display content from Vimeo
Google Maps
Consent to display content from Google